bpc 157 legal status us BPC-157 FDA panel votes to place
FDA panel votes to place popular peptide BPC 157 on compounding list Reuters Repost @peptides with @use.repost BREAKING NEWS! Today's 86 advisory vote for BPC 157 is one of the biggest peptide regulatory developments we've seen in years. While nothing changes immediately, the recommendation represents BIG NEWS in compounded peptide therapy. On February 27, HHS Secretary RFK Jr. announced his intent to move ~14 of 19 previously restricted peptides back to legal compounding status meaning BPC 157: A Prohibited Peptide and an Unapproved Drug Found in Health and Wellness Products FDA's Review Of Peptides Signals A Growing Public Health Challenge
Pay in 4 interest-free payments of $6.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10


